http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1556699-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26e19c12ac350fc1c0c02bcf301685e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_809af3db52a68d1016966d8f2cffad1b
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-553
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2facb068a0bf4e2e911a282a6931853
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9da5b4a92f125c4d0564924423f60f2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b588d644226c451118942d02d84b9846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c18d274cf648c6293f89bf67d92140ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4a85c82b47225a9a1255b7c4d59ef70
publicationDate 2005-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1556699-A2
titleOfInvention Method for ngf assay for in vitro diagnosis of breast cancer and therapeutic use
abstract The invention concerns a method for in vitro diagnosis of breast cancer which consists in determining the presence of NGF in a biological sample derived from a patient suspected of suffering from breast cancer. Said method may be used in early diagnosis, screening, therapeutic follow-up, prognosis, as well as in diagnosis of relapse in the case of breast cancer. The invention also concerns the use of an NGF binding partner or an NGF inhibitor for preparing a medicine, said medicine being in particular useful for blocking tumor proliferation and remote dissemination in patients suffering from breast cancer. The invention has diagnostic and therapeutic applications.
priorityDate 2002-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396689
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID110635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24868282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426548
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128045541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396196
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129915696
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11672965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129612837
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14844438

Total number of triples: 41.